Submitted:
03 June 2024
Posted:
03 June 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Subject Recruitment
2.2. Serologic Tests
2.3. Health Behavior Survey
2.4. Statistical Analysis
3. Results
4. Discussion
4.1. HBsAg and Anti-HCV Prevalence
4.2. Educational Level and Hepatitis B and C Viral Infections
4.3. Risky Health Behaviors and Hepatitis B and C Virus Infections
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. International Agency for Research on Cancer – Cancer Today. https://gco.iarc.fr/today/online-analysis-map?v=2020&mode=population&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=11&type=1&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=0&include_nmsc_other=0&projection=natural-earth&color_palette=default&map_scale=quantile&map_nb_colors=5&continent=0&show_ranking=0&rotate=%255B10%252C0%255D. (accessed on 20 September 2023).
- World Health Organization. International Agency for Research on Cancer- IARC News. https://www.iarc.who.int/news-events/world-hepatitis-day-2023/. (accessed on 20 September 2023).
- Korean Statistical Information Service (KOSIS). Population by sex & city, county, and district. https://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B04006&conn_path=I2. (accessed on 26 July 2023).
- Korean Statistical Information Service (KOSIS). Medical institutions by city, county, and district. https://kosis.kr/statHtml/statHtml.do?orgId=354&tblId=DT_HIRA4B&conn_path=I2. (accessed on 20 September 2023).
- Korean Statistical Information Service (KOSIS). Age-standardized cancer incidence by city, county, and district. https://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_117N_A11109&conn_path=I2. (accessed on 20 September 2023).
- Ryu DH, Lee YM, Park JM, Tak WY, Hong NS. Examining liver cancer patients and a high-risk group in vulnerable area: an experience from the Ulleung Liver Cancer Prevention and Management Project. International Journal of Environmental Research and Public Health. 2020; 17: 7757. [CrossRef]
- Shin HR, Kim JY, Lee DH, Yoo KY, Lee DS, Franceschi S. Hepatitis B and C virus prevalence in a rural area of South Korea: the role of acupuncture. British Journal of Cancer. 2002; 87: 314-318. [CrossRef]
- El-Chitany EM, Wahab MMA, El-Whab EWA, Hassouna S, Farghaly AG. A comprehensive hepatitis C virus risk factors meta-analysis (1989-2013): Do they differ in Egypt? Liver International. 2015; 35(2): 489-501. [CrossRef]
- Nielsen A, Kligler B, Koll BS. Safety protocols for Gua sha (press-stroking) and Baguan (cupping). Complementary Therapies in Medicine. 2012; 20(5): 340-344. [CrossRef]
- Park SM, Kim WJ, Mun JH, Kim HS, Ko HC, Kim BS, Kim MB, Song M. Adverse events associated with acupuncture: a clinicopathologic review. International Journal of Dermatology. 2016; 55(7): 757-763. [CrossRef]
- Kim GR. Survey of hepatitis B surface antigen in the sera of health adults in the Seoul and Gyunggi-do areas. Korean Journal of Virology. 1981; 11(1): 35-40.
- Ahn YO, Yoo KY, Park BJ. An epidemiologic study on risk factors of hepatitis B infection in Korea. Epidemiology and Health. 1987; 9(1): 57-65.
- Yoo KY, Park BJ, Ahn YO. Seroepidemiology of hepatitis B virus infection in healthy Korean adults in Seoul. Korean Journal of Preventive Medicine. 1988; 21(1): 89-97.
- Yim SY, Kim JH. The epidemiology of hepatitis B virus infection in Korea. Korean Journal of Internal Medicine. 2019; 34(5): 945-953. [CrossRef]
- Cui F, Blach S, Mingiedi CM, Conzalez MA, AAlaama AS, Mozalevkis A, Seguy N, Rewari BB, Chhan P, Le L, Doherty M, Luhmann N, Easterbrook P, Dirac M, de Martel C, Nayagam S, Hallett TB, Vickerman P, Razavi H, Lesi O, Low-beer D. Global reporting of progress towards elimination of hepatitis B and C. Lancet Gastroenterol Hepatol. 2023; 8(4): 332-342. [CrossRef]
- Korea Disease Control and Prevention Agency. Korea National Health and Nutrition Examination Survey. https://knhanes.kdca.go.kr/knhanes/sub04/sub04_04_01.do. (accessed on 20 September 2023).
- Kim DY, Jeong SH, Cho YK, Lee JH, Jin YJ, Lee D, Suh DJ, Han KH, Park NH, Kang HY, Jung YK, Kim YS, Kim KA, Lee YJ, Lee BS, Yim HJ, Lee HJ, Baik SK, Tak WY., Lee SJ, Chung WJ, Choi SK, Cho EY, Heo J, Kim DJ, Song BC, Kim MW, Lee J, Chae HB, Choi DH, Choi HY, Ki M. A nationwide seroepidemiology of hepatitis C virus infection in Korea. Liver International. 2013; 33(4): 586-894. [CrossRef]
- Shin HR, Hwang SY, Nam CM. The prevalence of hepatitis C virus infection in Korea: pooled analysis. Journal of Korean Medical Science. 2005; 20(6): 958-988. [CrossRef]
- Kweon SS, Cho SB. HCV epidemiology in Korea: focused on community based HCV epidemiological investigation at Jindo-gun. Single Topic Symposium. 2016; 1: 3-9.
- Wang CS, Chang TT, Yao WJ, Chou P. Comparison of hepatitis B virus and hepatitis C virus prevalence and risk factors in a community-based study. Am J Trop Med Hyg 2002; 66(4):389-393. [CrossRef]
- Community Health Survey. https://chs.kdca.go.kr/chs/stats/statsMain.do. (accessed on 26 July 2023).
- Koh WP, Robien K, Wang R, Govindarajan S, Yuan JM, Yu MC. Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. British Journal of Cancer. 2011; 105: 1430-1435. [CrossRef]
- Wang LY, You SL, Lu SN, Ho HC, Wu MH, Sun CA, Yang HI, Chen CJ. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes and Control. 2003; 14: 241-250. [CrossRef]
- Chuang SC, Lee YA, Dai M, Zheng T, Boffetta P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer epidemiology, biomarkers & prevention. 2010; 19(5): 1261-1268. [CrossRef]
- Silverman AL, Sekhon JS, Saginaw SJ, Wiedbrauk DW, Balasubramaniam M, Gordon SC. Tattoo application is not associated with an increased risk for chronic viral hepatitis. The American Journal of Gastroenterology. 2000; 95(5): 1312-1315. [CrossRef]
- Rehemann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature reviews immunology. 2005; 5: 215-229. [CrossRef]

| Variables | n (%) |
|---|---|
| Total | 1684 (100.0) |
| Sex | |
| Male | 840 (49.9) |
| Female | 844 (50.1) |
| Age | |
| 40-49 | 417 (24.8) |
| 50-59 | 531 (31.5) |
| 60-69 | 726 (43.1) |
| ≥70 | 10 (0.6) |
| Education | |
| ≤Elementary | 218 (13.0) |
| Junior high | 331 (19.7) |
| High | 660 (39.2) |
| ≥College | 475 (28.2) |
| Monthly household income (1000 KRW) | |
| <500 | 256 (15.2) |
| 500-999 | 170 (10.1) |
| 1000-1999 | 373 (22.2) |
| 2000-2999 | 330 (19.6) |
| 3000-3999 | 227 (13.5) |
| ≥4000 | 328 (19.5) |
| Residential period in Ulleung | |
| <1 year | 75 (4.5) |
| 1-9 years | 412 (24.5) |
| ≥10 years | 1197 (71.1) |
| Variables | HBsAg positivity | Anti-HCV positivity | ||||
|---|---|---|---|---|---|---|
| n (%) | Crude OR (95% CI) | Adjusted OR a (95% CI) | n (%) | Crude OR (95% CI) | Adjusted OR a (95% CI) | |
| Total | 121 (7.19) | - | 23 (1.37) | - | ||
| Sex | ||||||
| Male | 66 (7.86) | Reference | - | 10 (1.19) | Reference | - |
| Female | 55 (6.52) | 0.83 (0.59, 1.18) | - | 13 (1.54) | 1.41 (0.62, 3.19) | - |
| Age | ||||||
| 40-49 | 22 (5.45) | Reference | - | 5 (1.24) | Reference | - |
| 50-59 | 33 (6.21) | 1.15 (0.69, 1.92) | - | 8 (1.51) | 1.27 (0.41, 3.91) | - |
| 60-69 | 62 (8.54) | 1.50 (0.95, 2.38) | - | 9 (1.24) | 1.16 (0.39, 3.41) | - |
| ≥70 | 4 (40.00) | 13.18 (4.14, 41.94) | - | 1 (10.00) | 7.28 (0.79, 67.22) | - |
| Education | ||||||
| ≤Elementary | 27 (12.39) | 3.31 (1.86, 5.87) | 3.58 (1.79-7.15) | 5 (2.29) | 1.59 (0.50, 5.05) | 1.07 (0.25-4.53) |
| Jr. high | 29 (8.76) | 2.34 (1.34, 4.08) | 2.55 (1.35-4.81) | 3 (0.91) | 0.61 (0.16, 2.37) | 0.46 (0.10-2.11) |
| High | 43 (6.52) | 1.79 (1.08, 2.99) | 1.90 (1.12-3.21) | 8 (1.21) | 0.91 (0.34, 2.45) | 0.78 (0.28-2.19) |
| ≥College | 22 (4.63) | Reference | Reference | 7 (1.47) | Reference | Reference |
| Monthly household income (1000 KRW) | ||||||
| <500 | 22 (8.59) | 1.89 (1.01, 3.53) | 1.71 (0.85-3.43) | 1 (0.39) | 0.43 (0.04, 4.16) | 0.34 (0.03-3.55) |
| 500-999 | 19 (11.18) | 2.24 (1.16, 4.36) | 2.06 (1.01-4.21) | 1 (0.59) | 1.27 (0.21, 7.65) | 1.04 (0.16-6.86) |
| 1000-1999 | 28 (7.51) | 1.65 (0.91, 2.99) | 1.51 (0.81-2.82) | 10 (2.68) | 2.95 (0.81, 10.82) | 2.47 (0.63-9.62) |
| 2000-2999 | 20 (6.06) | 1.43 (0.77, 2.65) | 1.41 (0.75-2.64) | 7 (2.12) | 2.28 (0.59, 8.89) | 2.22 (0.56-8.74) |
| 3000-3999 | 15 (6.61) | 1.44 (0.73, 2.83) | 1.43 (0.73-2.81) | 1 (0.44) | 0.47 (0.05, 4.52) | 0.47 (0.05-4.57) |
| ≥4000 | 17 (5.18) | Reference | Reference | 3 (0.91) | Reference | Reference |
| Residential period in Ulleung | ||||||
| <1 year | 4 (5.33) | 0.54 (0.19, 1.49) | 0.57 (0.20-1.60) | 2 (2.67) | 2.37 (0.53-10.61) | 3.10 (0.66-14.52) |
| 1-9 years | 14 (3.40) | 0.45 (0.27, 0.73) | 0.48 (0.29-0.80) | 8 (1.94) | 1.67 (0.69-4.00) | 2.00 (0.80-5.01) |
| ≥10 years | 103 (8.60) | Reference | Reference | 13 (1.09) | Reference | Reference |
|
a Adjusted for sex and age Abbreviations: OR, odds ratio; CI, confidence interval; KRW, the currency of Korea (1000 KRW is approximately 1 USD) | ||||||
| Variables | HBsAg positivity | Anti-HCV positivity | |||||
|---|---|---|---|---|---|---|---|
| n (%) | Crude OR (95% CI) | Adjusted OR a (95% CI) | n (%) | Crude OR (95% CI) | Adjusted OR a (95% CI) | ||
| Cigarette smoking | |||||||
| Never | 57 (5.83) | Reference | Reference | 14 (1.43) | Reference | Reference | |
| Former | 35 (10.23) | 1.69 (1.11, 2.57) | 2.06 (1.12, 3.80) | 1 (0.29) | 0.19 (0.03, 1.46) | 1.70 (0.52, 5.56) | |
| Current | 29 (7.97) | 1.44 (0.95, 2.20) | 1.86 (1.03, 3.35) | 8 (2.20) | 1.40 (0.59, 3.33) | 0.28 (0.03, 2.53) | |
| Alcohol consumption | |||||||
| No | 54 (9.08) | Reference | Reference | 11 (1.85) | Reference | Reference | |
| Moderate | 42 (5.48) | 0.61 (0.42, 0.91) | 0.70 (0.47, 1.06) | 9 (1.17) | 0.70 (0.30, 1.67) | 0.74 (0.30, 1.85) | |
| Heavy | 25 (7.74) | 0.78 (0.49, 1.26) | 0.83 (0.48, 1.41) | 3 (0.93) | 0.49 (0.14, 1.76) | 0.59 (0.14, 2.43) | |
| Obesity | |||||||
| Normal | 39 (7.29) | Reference | Reference | 7 (1.31) | Reference | Reference | |
| Overweight | 31 (7.47) | 0.85 (0.53, 1.35) | 0.81 (0.50, 1.31) | 4 (0.96) | 0.66 (0.20, 2.21) | 0.69 (0.20, 2.38) | |
| Obese | 51(6.95) | 0.94 (0.64, 1.40) | 0.90 (0.60, 1.35) | 12 (1.63) | 1.12 (0.46, 2.76) | 1.31 (0.51, 3.34) | |
| Cancer screening | |||||||
| No | 18 (4.93) | 0.61 (0.38, 0.99) | 0.63 (0.38, 1.04) | 9 (2.47) | 2.17 (0.94, 4.99) | 2.44 (0.99, 6.04) | |
| Yes | 103 (7.81) | Reference | Reference | 14 (1.06) | Reference | Reference | |
|
a Adjusted for sex, age, education, monthly household income, and residential year in Ulleung. Abbreviations: OR, odds ratio; CI, confidence interval | |||||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).